Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

CUSIP: 69012T305

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
67,246,397
Total 13F shares
6,820,797
Share change
+2,400,449
Total reported value
$10,777,161
Put/Call ratio
460%
Price per share
$1.58
Number of holders
52
Value change
+$3,854,437
Number of buys
26
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q4 2025

As of 31 Dec 2025, Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,820,797 shares. The largest 10 holders included Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, BlackRock, Inc., GILPIN WEALTH MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.